×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Vasectomy Market Share

ID: MRFR/MED/3282-HCR
110 Pages
Rahul Gotadki
October 2025

Vasectomy Market Research Report Information By Type (Conventional Vasectomy, No-Scalpel Vasectomy, Minimally Invasive Vasectomy), Drug (Anesthetics, Painkillers, Antibiotics), Patient (Humans, Animals), End User (Hospitals And Clinics) - Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Vasectomy Market Infographic
Purchase Options

Market Share

Vasectomy Market Share Analysis

The reproductive health industry's vasectomy business is small but important since it includes male sterilization. Cultural perspectives, accessibility, and technology advances affect the permanent contraceptive industry. As more men choose vasectomy, the market for this safe and efficient birth control treatment has grown. Businesses seeking strategic positioning must comprehend market size and growth. Vasectomy companies engage in research and development to make operations less invasive and more convenient. Technology improves patient satisfaction and may induce more people to get vasectomy for birth control. Since vasectomy is irreversible, education is crucial to market share positioning. Businesses prioritize comprehensive educational programs for healthcare professionals and the public. Provide patients with facts on surgical safety, effectiveness, and reversibility to dispel myths. Building relationships with healthcare professionals is crucial. Companies teach medical personnel to perform vasectomy procedures properly. Collaboration with healthcare experts may also create a patient referral and endorsement network. Making vasectomy affordable is crucial to market entry. Companies are attempting to get insurance coverage for the therapy, remove financial barriers, and increase the number of individuals contemplating vasectomy for birth control. Businesses must understand the demographic factors that drive vasectomy decisions to adapt their marketing strategies. Tailoring marketing and outreach by age, culture, and socioeconomic status may be more successful. Companies consider global expansion, taking cultural and legal differences into consideration. Adapting one's approach to other places' demands and cooperating with foreign healthcare providers might help expand one's market reach. Offering post-vasectomy care and assistance sets you apart from competition. Businesses are developing follow-up instructions, fixing concerns, and offering vasectomy reversal to boost patient satisfaction and loyalty. Partnerships with NGOs and government health programs may boost market position. Collaborations may include raising awareness, funding marginalized group processes, and supporting larger-scale family planning operations. Successful market entry and success need regulatory framework navigation. Companies prioritize compliance with local and international laws, which compel them to ensure their products and services meet quality and safety requirements. Data analytics for market trends, patient outcomes, and competitor behavior is a key component of adaptive tactics. To be alert and adaptable to vasectomy market changes, companies invest in thorough monitoring systems.

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Leave a Comment

Market Summary

As per Market Research Future Analysis, the global vasectomy market is projected to grow at a CAGR of 7.4%, reaching a value of USD 27.46 billion from 2023 to 2032. Vasectomy Market is a permanent male sterilization procedure that effectively prevents pregnancy by cutting and sealing the vas deferens. The procedure is minimally invasive, typically completed in under 30 minutes, and allows patients to resume normal sexual activity within a week. The market is driven by increasing global population, hormonal disturbances, and rising gender equality, while challenges include the impact of COVID-19 on production and supply chains. The market is segmented by type, drugs, end-users, patients, and regions, with North America holding the largest market share due to high demand and advanced medical infrastructure.

Key Market Trends & Highlights

Key trends influencing the vasectomy market include technological advancements and changing societal attitudes towards male contraception.

  • Market expected to grow at a CAGR of 7.4% from 2023 to 2032.
  • North America holds the largest market share due to gender equality and healthcare demand.
  • COVID-19 pandemic significantly impacted production and supply chains.
  • Emerging technologies are creating new opportunities in the vasectomy market.

Market Size & Forecast

Market Size USD 27.46 Billion by 2032
CAGR 7.4%
Largest Regional Market North America
Market Segmentation By Type, Drugs, End-User, Patients, Region.

Major Players

Key players include Pfizer Inc., Abbott, GlaxoSmithKline plc, Sanofi S.A., Novartis AG, Bayer AG, Bristol Myers Squibb Company, Eli Lilly and Company Inc., Accurate Surgical & Scientific Instruments Corporation, and Sklar Surgical Instruments.

Market Trends

Vasectomy Market Market Drivers

Market Growth Projections

The Global Vasectomy Market Industry is projected to experience substantial growth in the coming years. With a current valuation of 16.8 USD Billion in 2024, the market is anticipated to reach 34.0 USD Billion by 2035. This represents a significant increase, driven by various factors including rising awareness of family planning, technological advancements, and changing societal attitudes towards male contraception. The expected compound annual growth rate (CAGR) of 6.63% from 2025 to 2035 further underscores the potential for expansion within this sector. These projections indicate a robust future for the vasectomy market as it adapts to evolving consumer needs and preferences.

Government Initiatives and Support

Government initiatives and support play a crucial role in shaping the Global Vasectomy Market Industry. Many countries have implemented policies aimed at promoting family planning and reproductive health services, which include vasectomy. These initiatives often provide funding for educational programs and subsidized healthcare services, making vasectomy more accessible to the public. For instance, countries with robust family planning programs report higher rates of vasectomy acceptance. This governmental backing not only raises awareness but also encourages men to consider vasectomy as a responsible choice, contributing to the projected CAGR of 6.63% for the period from 2025 to 2035.

Rising Awareness of Family Planning

The increasing awareness surrounding family planning and reproductive health is a pivotal driver for the Global Vasectomy Market Industry. Educational campaigns and healthcare initiatives have emphasized the importance of responsible parenthood, leading to a growing acceptance of vasectomy as a viable option for permanent contraception. This trend is particularly evident in developed nations, where the demand for vasectomies is on the rise. As of 2024, the Global Vasectomy Market is valued at 16.8 USD Billion, reflecting a shift in societal attitudes towards male sterilization. This awareness is expected to further bolster market growth as more individuals consider vasectomy as a practical solution.

Changing Attitudes Towards Male Contraception

Changing attitudes towards male contraception are reshaping the Global Vasectomy Market Industry. Traditionally, contraceptive responsibility has been predominantly placed on women, but there is a noticeable shift as men increasingly recognize the importance of sharing this responsibility. This evolving mindset is fostering a more open dialogue about male sterilization options, including vasectomy. As societal norms continue to evolve, more men are likely to consider vasectomy as a practical and responsible choice. This cultural shift is expected to drive market growth, aligning with the overall trend of increasing acceptance of male contraceptive methods.

Technological Advancements in Surgical Techniques

Technological advancements in surgical techniques are significantly influencing the Global Vasectomy Market Industry. Innovations such as no-scalpel vasectomy and advanced anesthesia methods have improved patient experiences and outcomes, leading to increased adoption rates. These minimally invasive procedures reduce recovery times and complications, making vasectomy a more appealing option for men. As healthcare providers adopt these modern techniques, the market is likely to witness a surge in demand. The anticipated growth trajectory suggests that by 2035, the market could reach 34.0 USD Billion, driven by these advancements that enhance the overall efficacy and safety of the procedure.

Increased Healthcare Access and Insurance Coverage

Increased healthcare access and insurance coverage are significant factors driving the Global Vasectomy Market Industry. As healthcare systems evolve, more individuals gain access to reproductive health services, including vasectomy. Insurance providers are increasingly covering the costs associated with the procedure, reducing financial barriers for potential patients. This trend is particularly pronounced in regions where healthcare reforms have expanded coverage for family planning services. As a result, more men are likely to opt for vasectomy, contributing to the market's growth trajectory. The combination of improved access and financial support is expected to enhance the overall adoption rates of vasectomy.

Market Segment Insights

Regional Insights

Key Companies in the Vasectomy Market market include

Industry Developments

Pfizer Inc. and BioNTech S.E. today announced that they had submitted an application to the U.S. Food and Drug Administration for emergency use authorization of an additional booster dose for the adults. The submission is completely based on the two-real world data sets from Israel.

Future Outlook

Vasectomy Market Future Outlook

The Global Vasectomy Market is projected to grow at a 6.63% CAGR from 2024 to 2035, driven by rising awareness, technological advancements, and increasing demand for permanent contraception.

New opportunities lie in:

  • Develop innovative minimally invasive vasectomy techniques to enhance patient comfort and recovery.
  • Expand telehealth services for pre- and post-operative consultations to improve accessibility.
  • Invest in educational campaigns targeting younger demographics to increase awareness and acceptance of vasectomy.

By 2035, the Vasectomy Market is expected to demonstrate robust growth, reflecting evolving societal attitudes towards family planning.

Market Segmentation

By Type

  • Conventional Vasectomy Market
  • No-scalpel Vasectomy Market
  • Minimally Invasive Vasectomy Market

By Drugs

  • Anesthetics
  • Painkillers
  • Antibiotics
  • Others

By End-User

  • Hospital & Clinics
  • Research and academics
  • Others

By Patients

  • Human
  • Animals

By Regional Sectors

  • Asia-Pacific
  • Europe
  • South America
  • North America
  • Middle East & Africa

Some of the key market players are

  • Pfizer Inc.
  • Abbott
  • GlaxoSmithKline plc.
  • Sanofi S.A.
  • Novartis AG
  • Bayer AG
  • Bristol Myers Squibb Company
  • Eli Lilly and Company Inc.
  • Accurate Surgical & Scientific Instruments Corporation
  • Sklar Surgical Instruments

Report Scope

Attribute/Metric Details
Market Size 2022 N/A (USD Billion)
Market Size 2023 N/A (USD Billion)
Market Size 2032 27.46 (USD Billion)
Compound Annual Growth Rate (CAGR) 7.4 % (2024- 2032)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year 2022
Market Forecast Period 2023 - 2032
Historical Data 2019 - 2022
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Pfizer, Inc., Abbott, GlaxoSmithKline plc, Sanofi S.A., Novartis AG, Bayer AG, Bristol Myers Squibb Company, Eli Lilly and Company, Inc., Accurate Surgical & Scientific Instruments Corporation, Sklar Surgical Instruments, Advanced Meditech International and others
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers Rising demand due to growing population Increasing male-female equality Side effects of female contraception

FAQs

  1. Report Prologue
  2. Market Introduction
    1. Definition
    2. Scope Of The Study
      1. Research Objective
      2. Limitations
    3. Assumptions
  3. Research Methodology
    1. Introduction
    2. Primary Research
    3. Secondary Research
    4. Market Size Estimation
  4. Market Dynamics
    1. Drivers
    2. Restrains
    3. Opportunities
    4. Challenges
    5. Macroeconomic Indicators
    6. Technology Trends &
    7. Assessment
  5. Market Factor Analysis
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    3. Investment Feasibility Analysis
    4. Pricing
    5. Analysis
  6. Global Vasectomy Market, By Type
    1. Introduction
      1. Market Estimates & Forecast, 2023-2030
    2. Conventional Vasectomy
    3. No-Scalpel Vasectomy
      1. Market Estimates & Forecast, 2023-2030
    4. Minimally Invasive Vasectomy
      1. Market Estimates & Forecast, 2023-2030
  7. Global Vasectomy Market, By Drugs
    1. Introduction
    2. Anesthetics
      1. Market Estimates & Forecast, 2023-2030
    3. Pain Killers
    4. Market Estimates & Forecast, 2023-2030
    5. Antibiotics
      1. Market
    6. Estimates & Forecast, 2023-2030
    7. Others
      1. Market Estimates
    8. & Forecast, 2023-2030
  8. Global Vasectomy Market, By Patients
    1. Introduction
    2. Humans
      1. Market Estimates & Forecast, 2023-2030
    3. Animals
      1. Market Estimates & Forecast, 2023-2030
  9. Global
  10. Vasectomy Market, By End-User
    1. Introduction
    2. Hospitals And Clinics
      1. Market Estimates & Forecast, 2023-2030
    3. Research And Academics
      1. Market Estimates & Forecast, 2023-2030
    4. Others
      1. Market
    5. Estimates & Forecast, 2023-2030
  11. Global Vasectomy Market, By Region
    1. Introduction
    2. Americas
      1. North America
      2. South America
    3. Europe
      1. Western
      2. Eastern
    4. Europe
    5. Italy
    6. Europe
    7. Asia Pacific
      1. Japan
      2. China
      3. India
      4. Australia
      5. Republic Of Korea
      6. Rest Of Asia Pacific
    8. The Middle East & Africa
      1. United Arab Emirates
      2. Oman
      3. Kuwait
      4. Qatar
      5. Rest
    9. Saudi Arabia
    10. Of The Middle East & Africa
  12. Company Landscape
    1. Introduction
    2. Market Share Analysis
    3. Key Development & Strategies
    4. Key Developments
  13. Company Profiles
    1. Pfizer, Inc.
      1. Overview
      2. Product Overview
      3. Financials
      4. Key GlaxoSmithKline
      5. Overview
      6. Product Overview
      7. Financials
      8. Key Developments
    2. Plc
    3. Sanofi S.A.
      1. Overview
      2. Financials
      3. Key Development
    4. Product Overview
    5. Accurate
      1. Overview
      2. Financials
      3. Key Development
    6. Surgical & Scientific Instruments Corporation
    7. Product Overview
    8. Sklar
      1. Overview
      2. Product Overview
      3. Key Development
    9. Surgical Instruments
    10. Financials
    11. Novartis AG
      1. Overview
      2. Product Overview
      3. Financials
      4. Key Development
    12. Abbott
      1. Overview
      2. Product Overview
      3. Financials
      4. Key Development
    13. Advanced Meditech International
      1. Overview
      2. Product Overview
      3. Financials
      4. Key Development
    14. Others
  14. MRFR Conclusion
    1. Key Findings
      1. From CEO’s
      2. Unmet Needs Of The Market
    2. View Point
    3. Key Companies To Watch
    4. Prediction Of Vasectomy Industry
  15. Appendix
    1. List Of Tables
  16. GLOBAL VASECTOMY MARKET, BY TYPE, 2023-2030 (USD MILLION)
    1. TABLE 2
  17. ASEPTIC ISOLATORS FOR VASECTOMY MARKET, BY REGION, 2023-2030 (USD MILLION)
    1. TABLE
  18. CONVENTIONAL VASECTOMY FOR VASECTOMY MARKET, BY REGION 2023-2030 (USD
    1. MILLION)
  19. NO-SCALPEL VASECTOMY FOR VASECTOMY MARKET, BY REGION 2023-2030 (USD MILLION)
  20. MINIMALLY INVASIVE VASECTOMY FOR VASECTOMY MARKET, BY REGION 2023-2030
    1. (USD MILLION)
  21. GLOBAL VASECTOMY MARKET, BY DRUGS, 2023-2030 (USD MILLION)
  22. ANESTHETICS FOR VASECTOMY MARKET, BY REGION, 2023-2030 (USD MILLION)
  23. PAIN KILLERS FOR VASECTOMY MARKET, BY REGION 2023-2030 (USD MILLION)
  24. ANTIBIOTICS FOR VASECTOMY MARKET, BY REGION 2023-2030 (USD MILLION)
  25. OTHERS FOR VASECTOMY MARKET, BY REGION 2023-2030 (USD MILLION)
    1. TABLE
  26. GLOBAL VASECTOMY MARKET, BY PATIENTS, 2023-2030 (USD MILLION)
  27. HUMANS
  28. FOR VASECTOMY MARKET, BY REGION, 2023-2030 (USD MILLION)
  29. ANIMALS FOR
  30. VASECTOMY MARKET, BY REGION 2023-2030 (USD MILLION)
  31. GLOBAL VASECTOMY
  32. MARKET, BY END USER, 2023-2030 (USD MILLION)
  33. NORTH AMERICA VASECTOMY
  34. MARKET, BY COUNTRY 2023-2030 (USD MILLION)
  35. NORTH AMERICA VASECTOMY
  36. MARKET, BY TYPE 2023-2030 (USD MILLION)
  37. NORTH AMERICA VASECTOMY MARKET,
    1. BY DRUGS 2023-2030 (USD MILLION)
  38. NORTH AMERICA VASECTOMY MARKET, BY
    1. PATIENTS 2023-2030 (USD MILLION)
  39. NORTH AMERICA VASECTOMY MARKET, BY
    1. END USER, 2023-2030 (USD MILLION)
  40. NORTH AMERICA VASECTOMY MARKET BY
    1. REGION 2023-2030 (USD MILLION
  41. EUROPE VASECTOMY MARKET, BY COUNTRY
  42. EUROPE VASECTOMY MARKET, BY TYPE 2023-2030
    1. (USD MILLION)
  43. EUROPE VASECTOMY MARKET, BY DRUGS 2023-2030 (USD MILLION)
  44. EUROPE VASECTOMY MARKET, BY PATIENTS 2023-2030 (USD MILLION)
    1. TABLE
  45. EUROPE VASECTOMY MARKET, BY END USER, 2023-2030 (USD MILLION)
  46. EUROPE
    1. VASECTOMY MARKET BY REGION 2023-2030 (USD MILLION)
  47. ASIA PACIFIC VASECTOMY
  48. MARKET, BY COUNTRY 2023-2030 (USD MILLION)
  49. ASIA PACIFIC VASECTOMY
  50. MARKET, BY TYPE 2023-2030 (USD MILLION)
  51. ASIA PACIFIC VASECTOMY MARKET,
    1. BY DRUGS 2023-2030 (USD MILLION)
  52. ASIA PACIFIC VASECTOMY MARKET, BY
    1. PATIENTS 2023-2030 (USD MILLION)
  53. ASIA PACIFIC VASECTOMY MARKET, BY
    1. END USER, 2023-2030 (USD MILLION)
  54. ASIA PACIFIC VASECTOMY MARKET BY
    1. REGION 2023-2030 (USD MILLION
  55. MIDDLE EAST & AFRICA VASECTOMY MARKET,
    1. BY COUNTRY 2023-2030 (USD MILLION)
  56. MIDDLE EAST & AFRICA VASECTOMY
  57. MARKET, BY TYPE 2023-2030 (USD MILLION)
  58. MIDDLE EAST & AFRICA VASECTOMY
  59. MARKET, BY DRUGS 2023-2030 (USD MILLION)
  60. MIDDLE EAST & AFRICA
  61. VASECTOMY MARKET, BY PATIENTS 2023-2030 (USD MILLION)
  62. MIDDLE EAST
  63. & AFRICA VASECTOMY MARKET, BY END USER, 2023-2030 (USD MILLION)
    1. TABLE 38
    2. MIDDLE EAST & AFRICA VASECTOMY MARKET BY REGION 2023-2030 (USD MILLION
    3. List
    4. Of Figures
  64. RESEARCH PROCESS
  65. MARKET DYNAMICS FOR GLOBAL
  66. VASECTOMY MARKET
  67. GLOBAL VASECTOMY MAKRET, BY SEGMENT, 2023
    1. FIGURE
  68. GLOBAL VASECTOMY SUCCESS MARKET, BY REGION
  69. GLOBAL VASECTOMY MARKET
    1. SHARE, BY TYPE 2023
  70. GLOBAL VASECTOMY MARKET SHARE, BY SYSTEM 2023
  71. GLOBAL VASECTOMY MARKET SHARE, BY PATIENTS 2023
  72. GLOBAL
  73. VASECTOMY MARKET SHARE, BY END USER, 2023
  74. GLOBAL VASECTOMY MARKET
    1. SHARE, 2023
  75. GLOBAL VASECTOMY MARKET SHARE, BY REGION, 2023
    1. FIGURE
  76. NORTH AMERICA VASECTOMY MARKET SHARE, BY COUNTRY, 2023
  77. EUROPE
  78. VASECTOMY MARKET SHARE, BY COUNTRY, 2023
  79. ASIA PACIFIC VASECTOMY MARKET
    1. SHARE, BY COUNTRY, 2023
  80. MIDDLE EAST & AFRICA VASECTOMY MARKET,
    1. BY REGION, 2023
  81. GLOBAL VASECTOMY MARKET: COMPANY SHARE ANALYSIS,
  82. ACCURATE SURGICAL & SCIENTIFIC INSTRUMENTS CORPORATION.:
    1. KEY FINANCIALS
  83. ACCURATE SURGICAL & SCIENTIFIC INSTRUMENTS CORPORATION.:
    1. SEGMENTAL REVENUE
  84. ACCURATE SURGICAL & SCIENTIFIC INSTRUMENTS
    1. CORPORATION.: GEOGRAPHICAL REVENUE
  85. PFIZER, INC.: KEY FINANCIALS
  86. PFIZER, INC.: SEGMENTAL REVENUE
  87. PFIZER, INC.: GEOGRAPHICAL
    1. REVENUE
  88. ADVANCED MEDITECH INTERNATIONAL: KEY FINANCIALS
    1. FIGURE
  89. ADVANCED MEDITECH INTERNATIONAL: SEGMENTAL REVENUE
  90. ADVANCED MEDITECH
    1. INTERNATIONAL: GEOGRAPHICAL REVENUE
  91. ABBOTT: KEY FINANCIALS
    1. FIGURE
  92. ABBOTT: SEGMENTAL REVENUE
  93. ABBOTT: GEOGRAPHICAL REVENUE
    1. FIGURE
  94. SKLAR SURGICAL INSTRUMENTS: FINANCIAL REVENUE
  95. SKLAR SURGICAL INSTRUMENTS:
    1. SEGMENTAL REVENUE
  96. SKLAR SURGICAL INSTRUMENTS: GEOGRPAHICAL REVENUE

Vasectomy Market Segmentation

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Comprehensive analysis by multiple parameters
  • Regional and country-level breakdowns
  • Market size forecasts by segment
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Customer Strories

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions